PGMP for Alberta Surgical Patients
Launched by UNIVERSITY OF CALGARY · Aug 31, 2021
Trial Information
Current as of August 22, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
Study design:
This stepped-wedge study(69) will evaluate cost effectiveness and implementation, clinical, and patient-reported outcomes.
Research question:
What are the effects of the PGMP on: (1) postoperative glycemic management; (2) length-of-stay; (3) readmission rates and (4) cost; compared to usual care in surgical patients admitted for ≥24-hours postoperatively?
Population:
Surgical patients at risk of hyperglycemia, admitted for ≥24-hours postoperatively. Pre-intervention sites serve as control groups.
Outcomes:
Change in length-of-stay is the primary effectiveness outcome, s...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Undergoing a surgical procedure, adults (older than 18 years of age), admitted to the hospital for more than 24 hours after their surgical procedure.
- Exclusion Criteria:
- • Under 18 years of age
About University Of Calgary
The University of Calgary is a leading research institution dedicated to advancing health and science through innovative clinical trials. With a strong emphasis on multidisciplinary collaboration, the university's clinical research initiatives aim to address pressing health challenges and improve patient outcomes. The institution fosters a robust environment for academic inquiry, leveraging state-of-the-art facilities and a diverse network of experts in various fields. Committed to ethical research practices and community engagement, the University of Calgary strives to translate scientific discoveries into tangible benefits for society.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Red Deer, Alberta, Canada
Calgary, Alberta, Canada
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials